These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21360968)

  • 1. [The safety of pharmacotherapy in the light of monitoring adverse drug reaction].
    Jabłecka A; Korzeniowska K
    Przegl Lek; 2010; 67(10):1091-2. PubMed ID: 21360968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of NSAIDs adverse effects based on spontaneous reports from Wrocław regional adverse drug reactions monitoring center.
    Jaźwińska-Tarnawska E; Wiela-Hojeńska A; Wolańczyk-Medrala A; Patkowski J; Nittner-Marszalska M; Głowacka K
    Acta Pol Pharm; 2012; 69(5):979-84. PubMed ID: 23061296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safety of medicinal products and reporting of adverse drug reactions].
    Skibicka I; Maciejczyk A
    Neurol Neurochir Pol; 2004; 38(6):503-10. PubMed ID: 15654675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reactions: treatment burdens and nurse-led medication monitoring.
    Gabe ME; Davies GA; Murphy F; Davies M; Johnstone L; Jordan S
    J Nurs Manag; 2011 Apr; 19(3):377-92. PubMed ID: 21507109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.
    Takata GS; Mason W; Taketomo C; Logsdon T; Sharek PJ
    Pediatrics; 2008 Apr; 121(4):e927-35. PubMed ID: 18381521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of pharmacists to the reporting of adverse drug reactions.
    van Grootheest AC; van Puijenbroek EP; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2002; 11(3):205-10. PubMed ID: 12051119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety monitoring of new anti-malarials in immediate post-marketing phase.
    Edwards IR
    Med Trop (Mars); 1998; 58(3 Suppl):93-6. PubMed ID: 10212911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adverse drug reaction: a clinical opportunity for pharmacists.
    Miller JD
    Hosp Pharm; 1995 Sep; 30(9):769-73. PubMed ID: 10151281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short patent lives jeopardize drug and patient safety.
    Hondeghem LM; De Clerck F; Camm J
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):353-7. PubMed ID: 18049301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacists' role in reporting adverse drug reactions in an international perspective.
    van Grootheest K; Olsson S; Couper M; de Jong-van den Berg L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):457-64. PubMed ID: 15269929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The incidence of drug side effects with reference to organ systems. Experience of the spontaneous reporting system of the Swiss Drug Side Effect Center and Comprehensive Drug Monitoring].
    Kuhn M; Hartmann K; Maibach R; Capaul R; Gartmann JC
    Ther Umsch; 1993 Jan; 50(1):8-12. PubMed ID: 8378869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a need for forensic pharmacovigilance as a specialty?
    Body D; Edwards IR; Hartigan Go K; Healy D; Herxheimer A; Labadie J
    Int J Risk Saf Med; 2011; 23(1):31-42. PubMed ID: 21507784
    [No Abstract]   [Full Text] [Related]  

  • 13. [Discussion on adverse reactions monitoring modes of drug manufacturers under new measures for administration of adverse drug reaction report and monitoring].
    Yang YY; Dong Z; Xia YP
    Zhongguo Zhong Yao Za Zhi; 2012 Nov; 37(21):3329-33. PubMed ID: 23397739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reporting system for adverse drug reactions and infections].
    Hashiguchi M; Mochizuki M
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():67-72. PubMed ID: 18074519
    [No Abstract]   [Full Text] [Related]  

  • 15. The importance of the pharmacist in reporting adverse drug reactions in the emergency department.
    Ratz Y; Shafir I; Berkovitch S; Sharristh M; Jacoby M; Kozer E; Golik A; Berkovitch M; Bar-Haim S
    J Clin Pharmacol; 2010 Oct; 50(10):1217-21. PubMed ID: 20418507
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of pharmacovigilance system in Ukraine: first results.
    Stefanov O; Sharayeva M; Jajtchenja V
    Pharmacoepidemiol Drug Saf; 2004 Mar; 13(3):197-9. PubMed ID: 15072120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring.
    Härmark L; van Hunsel F; Hak E; van Grootheest K
    Vaccine; 2011 Feb; 29(10):1941-7. PubMed ID: 21236235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.
    Blenkinsopp A; Wilkie P; Wang M; Routledge PA
    Br J Clin Pharmacol; 2007 Feb; 63(2):148-56. PubMed ID: 17274788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions detected by stimulated spontaneous reporting in an internal medicine department in Romania.
    Farcas A; Sinpetrean A; Mogosan C; Palage M; Vostinaru O; Bojita M; Dumitrascu D
    Eur J Intern Med; 2010 Oct; 21(5):453-7. PubMed ID: 20816604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacovigilance: characteristics of the most widely used drugs in Bulgaria.
    Getov I; Dimitrova Z
    Cent Eur J Public Health; 1999 Aug; 7(3):133-6. PubMed ID: 10499144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.